J. Goldman & CO LP Alkermes Plc. Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $1.44 Million - $1.69 Million
52,836 New
52,836 $1.48 Million
Q2 2022

Aug 15, 2022
BUY
$26.4 - $30.54 $4.57 Million - $5.29 Million
173,124 New
173,124 $5.16 Million
Q2 2021

Aug 16, 2021
SELL
$18.78 - $25.15 $1.13 Million - $1.51 Million
-60,074 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$18.21 - $23.2 $1.09 Million - $1.39 Million
60,074 New
60,074 $1.12 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email